James E. Flynn - 31 Dec 2024 SCHEDULE 13G/A Report for Prelude Therapeutics Incorporated Common Stock (PRLD)

Filing Manager
James E. Flynn
Reporting Manager
Deerfield Mgmt, L.P.
Security
Prelude Therapeutics Incorporated Common Stock
Symbol
PRLD
Disclosed Ownership
0 shares
Ownership
0%
Form type
SCHEDULE 13G/A
Filing time
13 Feb 2025, 08:58:41 UTC
Date of event
31 Dec 2024
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deerfield Mgmt, L.P. 0% 0 0 0 /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Management Company, L.P. 0% 0 0 0 /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Partners, L.P. 0% 0 0 0 /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
James E. Flynn 0% 0 0 0 /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact